EGD Masterclass: EoE, Strictures, and Pre-malignant Gastric Conditions (On-demand) | January 2023-Eosinophilic Esophagitis Medical and Diet Therapy

Video Transcription

Video Summary

In this video, the speaker discusses medical anti-therapy for eosinophilic esophagitis (EOE). They first mention their disclosures and involvement in multiple clinical trials for EOE. The video focuses on two main topics: updates on commonly used therapeutics and the role of biologics in EOE treatment. Previously, therapeutic options for EOE included drugs, diet, and dilation. Proton pump inhibitors (PPIs) are now considered first-line treatment options, while swallowed topical corticosteroids have shown efficacy in double-blind placebo-controlled trials. Dietary therapy options include elimination diets, with the elemental diet being the most effective but least practical. The speaker also discusses the use of biologic therapies, specifically Dupilumab, which has been FDA-approved for EOE treatment. Other advanced therapeutics are currently in development. The speaker emphasizes the importance of shared decision making in treatment selection.

Keywords

eosinophilic esophagitis

biologics

therapeutics

shared decision making

Dupilumab